The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain
|ClinicalTrials.gov Identifier: NCT01954199|
Recruitment Status : Completed
First Posted : October 1, 2013
Last Update Posted : June 2, 2016
|Condition or disease||Intervention/treatment|
|Nerve Pain Peripheral Nerve Injuries Peripheral Nervous System Diseases Sciatica Low Back Pain Low Back Ache Signs and Symptoms||Procedure: Neurodynamic Group|
Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain.
Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP.
Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain|
|Study Start Date :||March 2015|
|Primary Completion Date :||April 2016|
|Study Completion Date :||April 2016|
Experimental: Neurodynamic group
Patients allocated to this group will receive three different neurodynamic techniques: a lumbar foramen dynamic opener; a side-lying slider and a slider in the slump position. Patients will be asked to perform home exercises (a slider and a tensioner technique). Treatment will receive four treatments during two weeks (two sessions/week).
Procedure: Neurodynamic Group
All techniques will be executed in a pain-free way (grade III). Mild discomfort will be accepted, but it must subside as soon as the technique ends.
No Intervention: Control Group
Patients allocated to Control Group (CG) will receive no intervention and will be advised according to the best evidence available; i.e, advice to remain active and to resume activities of daily living
Upon trial completion, treatment will be offered.
- Leg Pain Intensity [ Time Frame: Two weeks after randomization ]Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS)
- Disability [ Time Frame: Two weeks after randomization ]Disability will be measured by the Oswestry Disability Index (ODI)
- Leg pain Intensity [ Time Frame: Four weeks after randomization ]Leg Pain will me measured by a 0-10 Pain NRS
- Disability [ Time Frame: Four weeks after randomization ]Disability will be measured by the Oswestry Disability Index (ODI)
- Back pain intensity [ Time Frame: Two weeks after randomization ]Back Pain will me measured by an 0-10 Pain NRS
- Back pain intensity [ Time Frame: Four weeks after randomization ]Back Pain will me measured by an 0-10 Pain NRS
- Distribution of Symptoms [ Time Frame: Two weeks, Four weeks after randomization ]Distribution of symptoms will me measured by a body diagram
- Function [ Time Frame: Two weeks, Four weeks after randomization ]Function will be measured by the Patient-Specific Functional Scale (PSFS)
- Global Perceived Effect [ Time Frame: Two weeks, Four weeks after randomization ]Global Perceived Effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01954199
|Federal University of Health Sciences of Porto Alegre|
|Porto Alegre, Rio Grande do sul, Brazil, 90050-170|
|Study Chair:||Marcelo F Silva, PhD||Federal University of Health Sciences of Porto Alegre|